Specimen Processing

Practical Breast Pathology

Volumn , Issue , 2012, Pages 15-23

  Kong, Christina S ^a,b   Jensen, Kristin C ^b,c  

^a Cytopathology Service   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84988561534     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-0763-2.00002-5     Document Type: Chapter

References (34)

1. P Argani (2003) Breast. WH Westra, RH Hruban, TH Phelps, C Isacson,(Eds) Surgical Pathology Dissection: An Illustrated Guide 2nd ed New York: Springer 132-140.
2. ME Hammond, DF Hayes, M Dowsett, et al. (2010) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. Arch Pathol Lab Med 134 907-922.
3. HER2 testing guidelines and resources: changes to the HER2 testing guideline, clinical notice. http://www.cap.org/apps/cap.portal?_nfpb=true&cntvwrPtlt_actionOverride=%2Fportlets%2FcontentViewer%2Fshow&_windowLabel=cntvwrPtlt&cntvwrPtlt{actionForm.contentReference}=committees%2Fimmunohistochemistry%2Fher2_index.html&_state=maximized&_pageLabel=cntvwr Available at
4. SC Lester (2010) Breast. Manual of Surgical Pathology Philadelphia: Elsevier Saunders 262-288.
5. SC Lester, S Bose, YY Chen, et al. (2009) Protocol for the examination of specimens from patients with invasive carcinoma of the breast. Arch Pathol Lab Med 133 1515-1538.
6. SC Lester, S Bose, YY Chen, et al. (2009) Protocol for the examination of specimens from patients with ductal carcinoma in situ of the breast. Arch Pathol Lab Med 133 15-25.
7. GM Varsegi and V Shidham (2009) Cell block preparation from cytology specimen with predominance of individually scattered cells. J Vis Exp http://digitalcommons.wayne.edu/med_path/4 Department of Pathology. Paper 4
8. PP Rosen (1991) Pathological assessment of nonpalpable breast lesions. Semin Surg Oncol 7 257-260.
9. M Rebner, MA Helvie, DR Pennes, et al. (1989) Paraffin tissue block radiography: adjunct to breast specimen radiography. Radiology 173 695-696.
10. JD Moritz, S Luftner-Nagel, JP Westerhof, et al. (1996) Microcalcifications in breast core biopsy specimens: disappearance at radiography after storage in formaldehyde. Radiology 200 361-363.
11. ME Hammond, DF Hayes, M Dowsett, et al. (2010) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. Arch Pathol Lab Med 134 907-922.
12. HER2 testing guidelines and resources: changes to the HER2 testing guideline, clinical notice. http://www.cap.org/apps/cap.portal?_nfpb=true&cntvwrPtlt_actionOverride=%2Fportlets%2FcontentViewer%2Fshow&_windowLabel=cntvwrPtlt&cntvwrPtlt{actionForm.contentReference}=committees%2Fimmunohistochemistry%2Fher2_index.html&_state=maximized&_pageLabel=cntvwr Available at
13. MA Molina, S Snell, D Franceschi, et al. (2009) Breast specimen orientation. Ann Surg Oncol 16 285-288.
14. LC Tong, N Nelson, J Tsourigiannis and AM Mulligan (2011) The effect of prolonged fixation on the immunohistochemical evaluation of estrogen receptor, progesterone receptor, and HER2 expression in invasive breast cancer: a prospective study. Am J Surg Pathol 35 545-552.
15. SBD Redfield, L Rezeanu and AS Brown (2011) Testing the limits: reevaluation of the upper limit of formalin fixation time recommended in the ASCO/CAP HER2 testing guidelines. Mod Pathol 24 59A.
16. ACNG Lowe, IP Shintaku, S Shapourifar-Tehrani, et al. (2011) Effect of ischemic time, fixation time and fixatives on HER-2/neu IHC and FISH results in breast cancer. Mod Pathol 24 52A.
17. AC Wolff, ME Hammond, JN Schwartz, et al. (2007) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25 118-145.
18. P Argani (2003) Breast. WH Westra, RH Hruban, TH Phelps, C Isacson,(Eds) Surgical Pathology Dissection: An Illustrated Guide 2nd ed New York: Springer 132-140.
19. SJ Schnitt and HH Wang (1989) Histologic sampling of grossly benign breast biopsies. How much is enough? Am J Surg Pathol 13 505-512.
20. SC Lester (2010) Breast. LC Lester,(Eds) Manual of Surgical Pathology Philadelphia: Elsevier Saunders 262-288.
21. S Sahoo and SC Lester (2009) Pathology of breast carcinomas after neoadjuvant chemotherapy: an overview with recommendations on specimen processing and reporting. Arch Pathol Lab Med 133 633-636.
22. DV Owings, L Hann and SJ Schnitt (1990) How thoroughly should needle localization breast biopsies be sampled for microscopic examination? A prospective mammographic/pathologic correlative study. Am J Surg Pathol 14 578-583.
23. J Rosai (2004) Guidelines for handling of most common and important surgical specimens. J Rosai,(Eds) Rosai and Ackerman's Surgical Pathology Philadelphia: Mosby 2919–2293
24. SC Lester, S Bose, YY Chen, et al. (2009) Protocol for the examination of specimens from patients with ductal carcinoma in situ of the breast. Arch Pathol Lab Med 133 15-25.
25. JW Carlson, RL Birdwell, EC Gombos, et al. (2007) MRI-directed, wire-localized breast excisions: incidence of malignancy and recommendations for pathologic evaluation. Hum Pathol 38 1754-1759.
26. Residual Cancer Burden Calculator http://www3.mdanderson.org/app/medcalc/index.cfm?pagename=jsconvert3 University of Texas, M.D. Anderson Center; 2011. Available at
27. TL Huston, R Pigalarga, MP Osborne and E Tousimis (2006) The influence of additional surgical margins on the total specimen volume excised and the reoperative rate after breast-conserving surgery. Am J Surg 192 509-512.
28. SC Abraham, K Fox, D Fraker, et al. (1999) Sampling of grossly benign breast reexcisions: a multidisciplinary approach to assessing adequacy. Am J Surg Pathol 23 316-322.
29. Standardized management of breast specimens recommended by Pathology Working Group, Breast Cancer Task Force. Am J Clin Pathol 60 789-798.
30. SB Edge, D Byrd, CC Compton, et al. (2010) Breast. AJCC Cancer Staging Manual 7th ed New York: Springer 353.
31. KK Khurana, A Loosmann, PJ Numann and SA Khan (2000) Prophylactic mastectomy: pathologic findings in high-risk patients. Arch Pathol Lab Med 124 378-381.
32. K Leunen, M Drijkoningen, P Neven, et al. (2008) Prophylactic mastectomy in familial breast carcinoma. What do the pathologic findings learn us? Breast Cancer Res Treat 107 79-86.
33. SL Spear, PM Parikh and JA Goldstein (2009) History of breast implants and the food and drug administration. Clin Plast Surg 36 15-21. v
34. SC Lester, S Bose, YY Chen, et al. (2009) Protocol for the examination of specimens from patients with invasive carcinoma of the breast. Arch Pathol Lab Med 133 1515-1538.